Nearly one million electronic cigarette products have yet to receive approval from the Food and Drug Administration for sale, while only 1,600 are regularly available on the US market. These figures were released by the FDA following the end of a lengthy verification process starting in April last year, when new federal laws came into effect granting the FDA the power to regulate tobacco products containing nicotine, including those not derived directly from tobacco but created in labs.
An anti-regulation campaign by consumers and businesses opposing restrictions on e-cigarettes has resulted in the release of a first set of data indicating that up to 890,000 products cannot be sold due to not meeting public health safety standards or incomplete documentation provided by the companies. Around 95% of requests have been processed so far.
The FDA has stated that no liquid containing synthetic nicotine has been authorized, therefore all products on the market will be considered illegal and sellers (wholesale and retail) will be punished. Among these companies is the popular brand Puff Bar, which essentially relates to disposable e-cigarettes and has been ordered to remove the device from the US market.
Statement:
This article is compiled from third-party information and is only intended for industry professionals' exchange and learning purposes.
This article does not represent the views of 2FIRSTS, and 2FIRSTS cannot confirm the truth or accuracy of the article's content. The translation of this article is only intended for industry communication and research purposes.
Due to limitations in our translation abilities, the translated article may not accurately reflect the original text. Please refer to the original article for accuracy.
2FIRSTS fully aligns with the Chinese government on all domestic, Hong Kong, Macau, Taiwan, and foreign-related statements and positions.
The copyright of the compiled information belongs to the original media and authors. If there is any infringement, please contact us to request removal.
Disclaimer
This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.
Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.
The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.
This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.
Copyright Notice
This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.
No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.
For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.
AI-Assisted Translation and Editing Notice
Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.
Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.
